Balance Sheet
AssetsCash & Current InvestmentsCommon EquityCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globe Life (GL) Cash & Equivalents (2016 - 2019)

Globe Life filings provide 11 years of Cash & Equivalents readings, the most recent being $67.3 million for Q1 2019.

  • Quarterly Cash & Equivalents fell 24.01% to $67.3 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $67.3 million through Mar 2019, down 24.01% year-over-year, with the annual reading at $121.0 million for FY2018, 2.08% up from the prior year.
  • Cash & Equivalents hit $67.3 million in Q1 2019 for Globe Life, down from $121.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $121.0 million in Q4 2018 and bottomed at $61.4 million in Q4 2015.
  • Average Cash & Equivalents over 5 years is $88.8 million, with a median of $82.4 million recorded in 2016.
  • The largest annual shift saw Cash & Equivalents skyrocketed 55.67% in 2017 before it dropped 24.01% in 2019.
  • Globe Life's Cash & Equivalents stood at $61.4 million in 2015, then increased by 24.08% to $76.2 million in 2016, then skyrocketed by 55.67% to $118.6 million in 2017, then grew by 2.08% to $121.0 million in 2018, then plummeted by 44.36% to $67.3 million in 2019.
  • Per Business Quant, the three most recent readings for GL's Cash & Equivalents are $67.3 million (Q1 2019), $121.0 million (Q4 2018), and $88.6 million (Q1 2018).